Drug Therapy
FDA/CDC
FDA gives nod to earlier use of Nplate in adults with ITP
The drug is now indicated for newly diagnosed and persistent adult patients with immune thrombocytopenia and an insufficient response to other...
News
Surgery better than medical therapy in some GERD patients
In some patients with persistent, treatment-refractory gastroesophageal reflux disease, surgery may be better than medical therapy.
Latest News
California bans “Pay for Delay,” promotes black maternal health, PrEP access
Two laws signed by Gov. Gavin Newsom addressed black maternal health and made PrEP available without a prescription.
FDA/CDC
FDA approves afamelanotide for treatment of rare condition with light-induced pain
This is the first treatment approved to help patients with erythropoietic protoporphyria increase their exposure to light.
Conference Coverage
Consider centralized pain in patients with rheumatic disease
LAS VEGAS – Every patient with chronic pain should complete a fibromyalgia survey, Dr. Daniel J. Clauw says.
Conference Coverage
What is the optimal duration of maintenance in myeloma?
SAN FRANCISCO – Dr. Yvonne A. Efebera and Dr. Nina Shah debate whether patients with multiple myeloma should receive maintenance until progression...
Conference Coverage
C-Path and NORD team up to speed development of treatments for rare disorders
ROCKVILLE - A new data analytics platform aims to accelerate therapies from bench to bedside for rare diseases.
Article
Strategies to reduce and prevent polypharmacy in older patients
Deprescribing can be accomplished by using tested tools, good judgment, and a team approach.